News Chart NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
1.21 ^USD	-0.82%		+2.54%	+54.14%

14/05	NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up	MT
07/05	NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients	CI

6e9bd11290ac45a158.kRe6NY93KFsRvy1inJrQQhOMfjMoqUqtDnmeMwNP80c.xXntQf9BcWhdhl1Xqs6bc3ztEWlshAnnQgvVfzYssCbWWvJB6kRbDH3YHQ~f8805286d4673cf67950ee9d18215a04